HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-OCT-12 4HGT TITLE CRYSTAL STRUCTURE OF CK1D WITH COMPOUND 13 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE I ISOFORM DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CKI-DELTA, CKID, TAU-PROTEIN KINASE CSNK1D; COMPND 5 EC: 2.7.11.1, 2.7.11.26; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK1D, HCKID; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CK1D, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.HUANG REVDAT 3 28-FEB-24 4HGT 1 REMARK SEQADV REVDAT 2 02-JUL-14 4HGT 1 JRNL REVDAT 1 21-NOV-12 4HGT 0 JRNL AUTH H.HUANG,L.ACQUAVIVA,V.BERRY,H.BREGMAN,N.CHAKKA,A.O'CONNOR, JRNL AUTH 2 E.F.DIMAURO,J.DOVEY,O.EPSTEIN,B.GRUBINSKA,J.GOLDSTEIN, JRNL AUTH 3 H.GUNAYDIN,Z.HUA,X.HUANG,L.HUANG,J.HUMAN,A.LONG,J.NEWCOMB, JRNL AUTH 4 V.F.PATEL,D.SAFFRAN,R.SERAFINO,S.SCHNEIDER,C.STRATHDEE, JRNL AUTH 5 J.TANG,S.TURCI,R.WHITE,V.YU,H.ZHAO,C.WILSON,M.W.MARTIN JRNL TITL STRUCTURE-BASED DESIGN OF POTENT AND SELECTIVE CK1 GAMMA JRNL TITL 2 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 3 1059 2012 JRNL REFN ISSN 1948-5875 JRNL PMID 24900428 JRNL DOI 10.1021/ML300278F REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 53122 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2699 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4551 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 553 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HGT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075448. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53247 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.15400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM CITRATE, 1.0 M LICL, 30% REMARK 280 PEG6000 , PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.48500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 LEU A 3 REMARK 465 ARG A 4 REMARK 465 VAL A 5 REMARK 465 GLY A 6 REMARK 465 ASN A 7 REMARK 465 ARG A 8 REMARK 465 LYS A 43 REMARK 465 THR A 44 REMARK 465 LYS A 45 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 GLY B 16 REMARK 465 SER B 17 REMARK 465 GLY B 18 REMARK 465 SER B 19 REMARK 465 PHE B 20 REMARK 465 GLY B 21 REMARK 465 LYS B 43 REMARK 465 THR B 44 REMARK 465 LYS B 45 REMARK 465 HIS B 46 REMARK 465 PRO B 47 REMARK 465 LEU B 293 REMARK 465 LYS B 294 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 13 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 46 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 160 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 221 CG CD CE NZ REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 223 CG CD OE1 NE2 REMARK 470 GLN A 271 CG CD OE1 NE2 REMARK 470 TYR A 284 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 294 CG CD CE NZ REMARK 470 ASP B 22 CG OD1 OD2 REMARK 470 GLN B 48 CG CD OE1 NE2 REMARK 470 TYR B 77 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 217 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 33 NH2 ARG A 69 2.00 REMARK 500 OD1 ASN B 143 O HOH B 599 2.12 REMARK 500 NH2 ARG B 10 O HOH B 566 2.14 REMARK 500 OD1 ASN B 291 O HOH B 599 2.17 REMARK 500 O HOH B 552 O HOH B 676 2.19 REMARK 500 O HOH B 592 O HOH B 638 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 173 CA - CB - CG ANGL. DEV. = 17.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 99 122.22 -174.20 REMARK 500 ASP A 128 46.68 -144.08 REMARK 500 ASP A 149 93.41 58.30 REMARK 500 ALA A 219 -77.19 -86.49 REMARK 500 ARG A 222 -20.15 -162.87 REMARK 500 TYR A 284 49.90 -80.05 REMARK 500 LEU B 85 -167.34 -113.94 REMARK 500 ASP B 128 52.93 -146.63 REMARK 500 LYS B 140 0.30 -57.83 REMARK 500 ASP B 149 88.38 65.29 REMARK 500 SER B 210 171.97 177.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15G A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15G B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HGL RELATED DB: PDB REMARK 900 RELATED ID: 4HGS RELATED DB: PDB DBREF 4HGT A 1 294 UNP P48730 KC1D_HUMAN 1 294 DBREF 4HGT B 1 294 UNP P48730 KC1D_HUMAN 1 294 SEQADV 4HGT GLY A -1 UNP P48730 EXPRESSION TAG SEQADV 4HGT SER A 0 UNP P48730 EXPRESSION TAG SEQADV 4HGT GLY B -1 UNP P48730 EXPRESSION TAG SEQADV 4HGT SER B 0 UNP P48730 EXPRESSION TAG SEQRES 1 A 296 GLY SER MET GLU LEU ARG VAL GLY ASN ARG TYR ARG LEU SEQRES 2 A 296 GLY ARG LYS ILE GLY SER GLY SER PHE GLY ASP ILE TYR SEQRES 3 A 296 LEU GLY THR ASP ILE ALA ALA GLY GLU GLU VAL ALA ILE SEQRES 4 A 296 LYS LEU GLU CYS VAL LYS THR LYS HIS PRO GLN LEU HIS SEQRES 5 A 296 ILE GLU SER LYS ILE TYR LYS MET MET GLN GLY GLY VAL SEQRES 6 A 296 GLY ILE PRO THR ILE ARG TRP CYS GLY ALA GLU GLY ASP SEQRES 7 A 296 TYR ASN VAL MET VAL MET GLU LEU LEU GLY PRO SER LEU SEQRES 8 A 296 GLU ASP LEU PHE ASN PHE CYS SER ARG LYS PHE SER LEU SEQRES 9 A 296 LYS THR VAL LEU LEU LEU ALA ASP GLN MET ILE SER ARG SEQRES 10 A 296 ILE GLU TYR ILE HIS SER LYS ASN PHE ILE HIS ARG ASP SEQRES 11 A 296 VAL LYS PRO ASP ASN PHE LEU MET GLY LEU GLY LYS LYS SEQRES 12 A 296 GLY ASN LEU VAL TYR ILE ILE ASP PHE GLY LEU ALA LYS SEQRES 13 A 296 LYS TYR ARG ASP ALA ARG THR HIS GLN HIS ILE PRO TYR SEQRES 14 A 296 ARG GLU ASN LYS ASN LEU THR GLY THR ALA ARG TYR ALA SEQRES 15 A 296 SER ILE ASN THR HIS LEU GLY ILE GLU GLN SER ARG ARG SEQRES 16 A 296 ASP ASP LEU GLU SER LEU GLY TYR VAL LEU MET TYR PHE SEQRES 17 A 296 ASN LEU GLY SER LEU PRO TRP GLN GLY LEU LYS ALA ALA SEQRES 18 A 296 THR LYS ARG GLN LYS TYR GLU ARG ILE SER GLU LYS LYS SEQRES 19 A 296 MET SER THR PRO ILE GLU VAL LEU CYS LYS GLY TYR PRO SEQRES 20 A 296 SER GLU PHE ALA THR TYR LEU ASN PHE CYS ARG SER LEU SEQRES 21 A 296 ARG PHE ASP ASP LYS PRO ASP TYR SER TYR LEU ARG GLN SEQRES 22 A 296 LEU PHE ARG ASN LEU PHE HIS ARG GLN GLY PHE SER TYR SEQRES 23 A 296 ASP TYR VAL PHE ASP TRP ASN MET LEU LYS SEQRES 1 B 296 GLY SER MET GLU LEU ARG VAL GLY ASN ARG TYR ARG LEU SEQRES 2 B 296 GLY ARG LYS ILE GLY SER GLY SER PHE GLY ASP ILE TYR SEQRES 3 B 296 LEU GLY THR ASP ILE ALA ALA GLY GLU GLU VAL ALA ILE SEQRES 4 B 296 LYS LEU GLU CYS VAL LYS THR LYS HIS PRO GLN LEU HIS SEQRES 5 B 296 ILE GLU SER LYS ILE TYR LYS MET MET GLN GLY GLY VAL SEQRES 6 B 296 GLY ILE PRO THR ILE ARG TRP CYS GLY ALA GLU GLY ASP SEQRES 7 B 296 TYR ASN VAL MET VAL MET GLU LEU LEU GLY PRO SER LEU SEQRES 8 B 296 GLU ASP LEU PHE ASN PHE CYS SER ARG LYS PHE SER LEU SEQRES 9 B 296 LYS THR VAL LEU LEU LEU ALA ASP GLN MET ILE SER ARG SEQRES 10 B 296 ILE GLU TYR ILE HIS SER LYS ASN PHE ILE HIS ARG ASP SEQRES 11 B 296 VAL LYS PRO ASP ASN PHE LEU MET GLY LEU GLY LYS LYS SEQRES 12 B 296 GLY ASN LEU VAL TYR ILE ILE ASP PHE GLY LEU ALA LYS SEQRES 13 B 296 LYS TYR ARG ASP ALA ARG THR HIS GLN HIS ILE PRO TYR SEQRES 14 B 296 ARG GLU ASN LYS ASN LEU THR GLY THR ALA ARG TYR ALA SEQRES 15 B 296 SER ILE ASN THR HIS LEU GLY ILE GLU GLN SER ARG ARG SEQRES 16 B 296 ASP ASP LEU GLU SER LEU GLY TYR VAL LEU MET TYR PHE SEQRES 17 B 296 ASN LEU GLY SER LEU PRO TRP GLN GLY LEU LYS ALA ALA SEQRES 18 B 296 THR LYS ARG GLN LYS TYR GLU ARG ILE SER GLU LYS LYS SEQRES 19 B 296 MET SER THR PRO ILE GLU VAL LEU CYS LYS GLY TYR PRO SEQRES 20 B 296 SER GLU PHE ALA THR TYR LEU ASN PHE CYS ARG SER LEU SEQRES 21 B 296 ARG PHE ASP ASP LYS PRO ASP TYR SER TYR LEU ARG GLN SEQRES 22 B 296 LEU PHE ARG ASN LEU PHE HIS ARG GLN GLY PHE SER TYR SEQRES 23 B 296 ASP TYR VAL PHE ASP TRP ASN MET LEU LYS HET 15G A 301 28 HET 15G B 301 28 HETNAM 15G 2-{2-[(3,4-DIFLUOROPHENOXY)METHYL]-5-METHOXYPYRIDIN-4- HETNAM 2 15G YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE FORMUL 3 15G 2(C20 H17 F2 N3 O3) FORMUL 5 HOH *553(H2 O) HELIX 1 1 GLN A 48 GLN A 60 1 13 HELIX 2 2 SER A 88 CYS A 96 1 9 HELIX 3 3 SER A 101 LYS A 122 1 22 HELIX 4 4 LYS A 130 ASP A 132 5 3 HELIX 5 5 LEU A 138 GLY A 142 5 5 HELIX 6 6 THR A 176 ALA A 180 5 5 HELIX 7 7 SER A 181 LEU A 186 1 6 HELIX 8 8 SER A 191 GLY A 209 1 19 HELIX 9 9 GLN A 223 THR A 235 1 13 HELIX 10 10 PRO A 236 CYS A 241 1 6 HELIX 11 11 PRO A 245 SER A 257 1 13 HELIX 12 12 ASP A 265 GLY A 281 1 17 HELIX 13 13 PHE A 288 LEU A 293 5 6 HELIX 14 14 LEU B 49 GLN B 60 1 12 HELIX 15 15 SER B 88 CYS B 96 1 9 HELIX 16 16 SER B 101 LYS B 122 1 22 HELIX 17 17 LYS B 130 ASP B 132 5 3 HELIX 18 18 LEU B 138 GLY B 142 5 5 HELIX 19 19 SER B 181 LEU B 186 1 6 HELIX 20 20 SER B 191 GLY B 209 1 19 HELIX 21 21 THR B 220 THR B 235 1 16 HELIX 22 22 PRO B 236 CYS B 241 1 6 HELIX 23 23 SER B 246 LEU B 258 1 13 HELIX 24 24 ASP B 265 GLN B 280 1 16 HELIX 25 25 PHE B 288 MET B 292 5 5 SHEET 1 A 5 ARG A 10 SER A 17 0 SHEET 2 A 5 ASP A 22 ASP A 28 -1 O THR A 27 N ARG A 10 SHEET 3 A 5 GLU A 33 CYS A 41 -1 O ILE A 37 N TYR A 24 SHEET 4 A 5 TYR A 77 GLU A 83 -1 O MET A 82 N ALA A 36 SHEET 5 A 5 ILE A 68 GLU A 74 -1 N GLY A 72 O VAL A 79 SHEET 1 B 2 PHE A 124 ILE A 125 0 SHEET 2 B 2 LYS A 154 LYS A 155 -1 O LYS A 154 N ILE A 125 SHEET 1 C 2 PHE A 134 MET A 136 0 SHEET 2 C 2 VAL A 145 ILE A 147 -1 O TYR A 146 N LEU A 135 SHEET 1 D 6 ARG B 4 VAL B 5 0 SHEET 2 D 6 TYR B 9 LYS B 14 -1 O TYR B 9 N VAL B 5 SHEET 3 D 6 ILE B 23 ASP B 28 -1 O LEU B 25 N GLY B 12 SHEET 4 D 6 GLU B 33 CYS B 41 -1 O ILE B 37 N TYR B 24 SHEET 5 D 6 TYR B 77 GLU B 83 -1 O ASN B 78 N GLU B 40 SHEET 6 D 6 ILE B 68 GLU B 74 -1 N GLY B 72 O VAL B 79 SHEET 1 E 2 PHE B 124 ILE B 125 0 SHEET 2 E 2 LYS B 154 LYS B 155 -1 O LYS B 154 N ILE B 125 SHEET 1 F 2 PHE B 134 MET B 136 0 SHEET 2 F 2 VAL B 145 ILE B 147 -1 O TYR B 146 N LEU B 135 SITE 1 AC1 17 ILE A 15 GLY A 18 ILE A 23 LEU A 25 SITE 2 AC1 17 ALA A 36 LYS A 38 PRO A 66 MET A 82 SITE 3 AC1 17 GLU A 83 LEU A 85 ILE A 148 ASP A 149 SITE 4 AC1 17 HOH A 436 HOH A 574 GLU B 2 ARG B 10 SITE 5 AC1 17 LEU B 11 SITE 1 AC2 21 THR A 27 GLY A 32 HOH A 476 ARG B 13 SITE 2 AC2 21 ILE B 15 ILE B 23 ALA B 36 LYS B 38 SITE 3 AC2 21 PRO B 66 MET B 82 GLU B 83 LEU B 84 SITE 4 AC2 21 LEU B 85 GLY B 86 LEU B 135 ILE B 148 SITE 5 AC2 21 ASP B 149 HOH B 452 HOH B 525 HOH B 560 SITE 6 AC2 21 HOH B 619 CRYST1 49.170 72.970 89.330 90.00 103.63 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020338 0.000000 0.004931 0.00000 SCALE2 0.000000 0.013704 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011519 0.00000